NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-078718 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 27, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
918,879
Total Value
$10,575,091.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Ordinary Shares | โ | Feb 24, 2026 | Exercise/Conversion | 64,708 | โ | โ | 524,567 | Direct | โ | View Details | |
Director | Ordinary Shares | โ | Feb 24, 2026 | Sale | 61,547 | $36.13 | $2,223,693.11 | 463,020 | Direct | โ | View Details | |
Director | Ordinary Shares | โ | Feb 24, 2026 | Sale | 3,161 | $36.46 | $115,250.06 | 459,859 | Direct | โ | View Details | |
Director | Ordinary Shares | โ | Feb 25, 2026 | Exercise/Conversion | 58,253 | โ | โ | 518,112 | Direct | โ | View Details | |
Director | Ordinary Shares | โ | Feb 25, 2026 | Sale | 46,517 | $35.11 | $1,633,211.87 | 471,595 | Direct | โ | View Details | |
Director | Ordinary Shares | โ | Feb 25, 2026 | Sale | 10,436 | $35.96 | $375,278.56 | 461,159 | Direct | โ | View Details | |
Director | Ordinary Shares | โ | Feb 25, 2026 | Sale | 1,300 | $36.68 | $47,684.00 | 459,859 | Direct | โ | View Details | |
Director | Ordinary Shares | โ | Feb 26, 2026 | Exercise/Conversion | 183,332 | โ | โ | 643,191 | Direct | โ | View Details | |
Director | Ordinary Shares | โ | Feb 26, 2026 | Sale | 165,408 | $33.63 | $5,562,671.04 | 477,783 | Direct | โ | View Details | |
Director | Ordinary Shares | โ | Feb 26, 2026 | Sale | 17,924 | $34.44 | $617,302.56 | 174,144 | Direct | โ | View Details | |
Director | Option (right to buy) | Derivative | Feb 24, 2026 | Exercise/Conversion | 64,708 | $0.00 | $0.00 | 924,559 | Direct | โ | View Details | |
Director | Option (right to buy) | Derivative | Feb 25, 2026 | Exercise/Conversion | 58,253 | $0.00 | $0.00 | 866,306 | Direct | โ | View Details | |
Director | Option (right to buy) | Derivative | Feb 26, 2026 | Exercise/Conversion | 183,332 | $0.00 | $0.00 | 682,974 | Direct | โ | View Details |